Cargando…

Vaccination Guidelines for Patients with Immune-Mediated Disorders on Immunosuppressive Therapies—Executive Summary

The use of immunosuppressive therapies for immune-mediated disease (IMD) is associated with an elevated risk of infections and related comorbidities. While many infectious diseases can generally be prevented by vaccines, immunization rates in this specific patient population remain suboptimal, due i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papp, Kim A, Haraoui, Boulos, Kumar, Deepali, Marshall, John K, Bissonnette, Robert, Bitton, Alain, Bressler, Brian, Gooderham, Melinda, Ho, Vincent, Jamal, Shahin, Pope, Janet E, Steinhart, A Hillary, Vinh, Donald C, Wade, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785689/ https://www.ncbi.nlm.nih.gov/pubmed/31616855 http://dx.doi.org/10.1093/jcag/gwy069

Ejemplares similares

Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive Therapies [Image: see text]
por: Papp, Kim A., et al.
Publicado: (2018)

Persistence of Tofacitinib in the Treatment of Rheumatoid Arthritis in Open‐Label, Long‐Term Extension Studies up to 9.5 Years
por: Pope, Janet E., et al.
Publicado: (2019)

Do patients with active RA have differences in disease activity and perceptions if anti-TNF naïve versus anti-TNF experienced? Baseline results of the optimization of adalimumab trial
por: Pope, Janet, et al.
Publicado: (2012)

Real-World Tocilizumab Use in Patients with Rheumatoid Arthritis in Canada: 12-Month Results From an Observational, Noninterventional Study
por: Haraoui, Boulos, et al.
Publicado: (2018)

Executive Summary
Publicado: (2006)

Executive summary
por: Gardner, C D
Publicado: (2012)

Executive summary()
Publicado: (2004)

Executive Summary
por: Geisenberger, Richard J., et al.
Publicado: (2022)

Effectiveness of a treat-to-target strategy in patients with moderate to severely active rheumatoid arthritis treated with abatacept
por: Bessette, Louis, et al.
Publicado: (2023)

Selective Phosphodiesterase Inhibitors for Psoriasis: Focus on Apremilast
por: Gooderham, Melinda, et al.
Publicado: (2015)

Introduction and executive summary
por: Nilsson, T, et al.
Publicado: (2006)

Reduction in Serum Uric Acid May Be Related to Methotrexate Efficacy in Early Rheumatoid Arthritis: Data from the Canadian Early Arthritis Cohort (CATCH)
por: Lee, Jason J., et al.
Publicado: (2016)

The 2023 Impact of Inflammatory Bowel Disease in Canada: Executive Summary
por: Windsor, Joseph W, et al.
Publicado: (2023)

Executive Summary: Gigasensors for an Attoscope
por: Heijne, Erik H M
Publicado: (2008)

TWEPP-07 Executive Summary
por: Christiansen, J, et al.
Publicado: (2007)

TWEPP-09 Executive summary
por: Christiansen, J, et al.
Publicado: (2009)

The Canadian Methotrexate and Etanercept Outcome Study: a randomised trial of discontinuing versus continuing methotrexate after 6 months of etanercept and methotrexate therapy in rheumatoid arthritis
por: Pope, Janet E, et al.
Publicado: (2014)

The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis
por: Roubille, Camille, et al.
Publicado: (2015)

Etanercept in the treatment of rheumatoid arthritis
por: Haraoui, Boulos, et al.
Publicado: (2007)

Physics on stage: executive summary 2000
por: Eur. Space Agency
Publicado: (2000)

Sensitizing properties of proteins: executive summary
por: Poulsen, Lars K, et al.
Publicado: (2014)

Safety considerations for IGRT: Executive summary
por: Jaffray, David A., et al.
Publicado: (2013)

Safety considerations for IMRT: Executive summary
por: Moran, Jean M., et al.
Publicado: (2011)

Two-year radiographic and clinical outcomes from the Canadian Methotrexate and Etanercept Outcome study in patients with rheumatoid arthritis
por: Keystone, Edward C., et al.
Publicado: (2016)

Impact of the environment on reproductive health: executive summary.
por: Michal, F, et al.
Publicado: (1993)

Executive Summary: Aligning Stakeholder Incentives in Orthopaedics
por: Wilson, Natalia A., et al.
Publicado: (2009)

Executive Summary of the Guidelines on Stable Coronary Disease
por: César, Luiz Antonio Machado, et al.
Publicado: (2015)

Rehabilitation medicine summit: building research capacity Executive Summary
por: Frontera, Walter R, et al.
Publicado: (2006)

Real World Effectiveness of Golimumab Therapy in Ulcerative Colitis Regardless of Prior TNF Exposure
por: Bressler, Brian, et al.
Publicado: (2018)

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Executive Summary
por: Ellen Kuenzig, M, et al.
Publicado: (2021)

Heterogeneous Disease Trajectories Explain Variable Radiographic, Function and Quality of Life Outcomes in the Canadian Early Arthritis Cohort (CATCH)
por: Barnabe, Cheryl, et al.
Publicado: (2015)

Variability in Executive Control Performance Is Predicted by Physical Activity
por: Gooderham, G. Kyle, et al.
Publicado: (2020)

Treatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a Phase 2b randomized clinical trial
por: Papp, Kim A., et al.
Publicado: (2016)

Quality Improvement in Neurology: Dementia Management Quality Measures (Executive Summary)
por: Odenheimer, Germaine, et al.
Publicado: (2013)

Corrigendum: Variability in Executive Control Performance Is Predicted by Physical Activity
por: Gooderham, G. Kyle, et al.
Publicado: (2020)

Studies on Monitoring and Tracking Genetic Resources: An Executive Summary
por: Garrity, George M., et al.
Publicado: (2009)

Executive Summary: Standards of Medical Care in Diabetes—2009
Publicado: (2009)

2003 Canadian Asthma Consensus Guidelines Executive Summary
por: Becker, Allan, et al.
Publicado: (2006)

Executive Summary: Standards of Medical Care in Diabetes—2011
Publicado: (2011)

Executive Summary: Standards of Medical Care in Diabetes—2010
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_qci5l0caf1jl77lu9a4h70eh9o